Description: Medmix AG designs, develops, manufactures, and delivers high-precision devices and services for the mixing, application, and injection of liquids in a range of viscosities for the healthcare, consumer, and industrial end markets worldwide. It operates through five segments: Dental, Drug Delivery, Surgery, Industry, and Beauty. The Dental segment offers mixing tips, dispensers, needles, accessories, and service solutions for various applications, such as prosthetics, restorations, anesthetics, and aesthetics. The Drug Delivery segment offers drug delivery devices that are used to inject fertility drugs and growth hormones; and to treat niche diabetes indications, osteoporosis, and rare diseases. The Surgery segment provides mixing and delivery devices which are used to inject bone cement, and to apply hemostatic sealants for internal and external wound treatment during surgical procedures. The Industry segment produces and markets dispensers, cartridges, and mixers for two-component adhesives and sealants for use in the construction, transportation, electronics, infrastructure, and general industrial sectors. The Beauty segment offers micro brushes, mascara, lip gloss and concealers. The company offers its products under the Mixpac, Transcodent, Cox, MK, Medmix, Haselmeier, and Geka brands. The company was founded in 1922 and is based in Zug, Switzerland.
Home Page: www.medmix.swiss
Dammstrasse 19
Zug,
6300
Switzerland
Phone:
41 4 1723 7300
Officers
| Name | Title |
|---|---|
| Mr. Girts Cimermans | Chief Exec. Officer |
| Ms. Jennifer Dean | Chief Financial Officer |
| Ms. Itee Satpathy | Chief HR Officer |
Exchange: SW
Country: CH
Currency: Swiss Franc (CHF)
| Forward PE: | 10.9051 |
|---|---|
| Trailing PE: | 14.8727 |
| Price-to-Book MRQ: | 1.2781 |
| Price-to-Sales TTM: | 1.3956 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 2101 |